InvestorsHub Logo
Post# of 253265
Next 10
Followers 2
Posts 401
Boards Moderated 0
Alias Born 01/15/2007

Re: None

Wednesday, 04/02/2008 11:46:58 AM

Wednesday, April 02, 2008 11:46:58 AM

Post# of 253265
Any insight on 'ONCONASE' here?

The new cancer drug 'ONCONASE' just completed their 7 year P3B FDA trial today. ACEL will now analize the results and announce the conclusions within one month. ACEL has a rolling NDA going and announced that they will file the completed NDA within 4 months of today's conclusion of trial PR news.

They have "fast-track" and "orphan drug" statuses already approved by the FDA. Dr. David Sidransky of John's Hopkins is their chairman and they have already signed a USA licensing agreement with Par Pharma.

Any knowledge or insight here on ONCONASE's possibilities.

Anyone here knowledgeable on the science behind the drug?

Does this drug have real possibilities to be helpful and effective?

Many thanks in advance for any insight, thoughts or opinions here.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.